Researchers tested dupilumab on various patient groups with atopic dermatitis (AD) to see how this treatment impacted all-cause and AD-related hospitalization rates.
Researchers tested dupilumab on various patient groups with atopic dermatitis (AD) to see how this treatment impacted all-cause and AD-related hospitalization rates.
At the recent Skin of Color Update in New York, Andrew F. Alexis, MD, reviewed important considerations for diagnosing and treating atopic dermatitis in patients with skin of color.
In a recent study, researchers examined how the early introduction of dietary fish or cod liver oil could affect the risk of developing eczema, wheezing, and asthma in young children.